Bruce & Co’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.84M Hold
2,000
0.53% 28
2025
Q4
$2.15M Hold
2,000
0.67% 27
2025
Q3
$1.53M Hold
2,000
0.47% 28
2025
Q2
$1.56M Hold
2,000
0.51% 27
2025
Q1
$1.65M Hold
2,000
0.53% 25
2024
Q4
$1.54M Buy
+2,000
New +$1.66M 0.5% 25

Other funds holding LLY

Bruce & Co's LLY Position: Q1 2026 in Review

Bruce & Co held its Eli Lilly (LLY) position steady in Q1 2026 at 2,000 shares worth $1.84M. The position accounts for 0.53% of the portfolio, ranked #28.

Bruce & Co first reported a position in LLY in Q4 2024 and has held it in 6 quarters since. The position peaked at $2.15M in Q4 2025. 4,352 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Bruce & Co held 2,000 shares of Eli Lilly worth $1.84M as of Q1 2026.
  • Bruce & Co left its Eli Lilly share count unchanged in Q1 2026.
  • Eli Lilly made up 0.53% of Bruce & Co's portfolio in Q1 2026, its #28 holding.
  • Bruce & Co first reported a position in Eli Lilly in Q4 2024 and has held it in 6 quarters since.
  • Bruce & Co's Eli Lilly position peaked at $2.15M in Q4 2025.
  • 4,352 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Bruce & Co's 13F filing for Q1 2026, filed 14 May 2026.